In conclusion, Alpinetin has a protective effect on COPD, which can inhibit apoptosis and reduce the release of inflammatory factors by reducing the activities of TGF‐β1, TNF‐α, and α‐SMA. This evidence concerns the gene TGFB1 and chronic obstructive pulmonary disease.